2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole

Product Details

CAS No:152628-02-9

MF:C19H20N4

Appearance:white or light-yellow crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole, CAS 152628-02-9, Telmisartan intermediate, Telmisartan Side Chain.CAS 152628-02-9 factory price, High purity Telmisartan intermediate, 2-propyl-4-methyl-6-(1'-methyl-1H-benzimidazol-2-yl)-1H-benzimidazole manufacturer, API intermediate for Antihypertensive, Pharmaceutical grade benzimidazole derivative.

Synonyms:2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole; 1,7'-diMethyl-2'-propyl-1H,3'H-;TelMisartan IMpurity A(2-n-propyl-4-Methyl-6-(1-MethylbenziMidazole-2-yl)benziMidazole);TelMisartan IMpurity A;TelMisartan Related CoMpound A;4-Methyl-2-propyl-6-benziMidazolecarboxylic Acid, 97+%;2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole;Imp. A:2-n-Propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole;1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazole; 4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole,"152628-02-9; 1,7'-DIMETHYL-2'-PROPYL-1H,1'H-2,5'-BIBENZO[D]IMIDAZOLE; 4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole; 6LS25C273E; 2-PROPYL-4-METHYL-6-(1-METHYLBENZIMIDAZOL-2-YL)BENZIMIDAZOLE; DTXSID20165089; TELMISARTAN IMPURITY A [EP IMPURITY]; TELMISARTAN IMPURITY A (EP IMPURITY); 1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo(d)imidazole; DTXCID9087580; 440-240-7; 604-866-6; 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole; MFCD03840857; 1,7'-Dimethyl-2'-propyl-2,5'-bibenzimidazole; 2,5'-BI-1H-BENZIMIDAZOLE, 1,7'-DIMETHYL-2'-PROPYL-; 4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-1H-benzimidazole; C19H20N4; 2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazole; N-Des((4-(2-carboxyphenyl)phenyl)methyl) telmisartan; 1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo(d)imidazole; 1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOLE; Telmisartan EP Impurity A; 4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazole; UNII-6LS25C273E; Telmisartan specified impurity A [EP]; SCHEMBL159014; SCHEMBL160346; SCHEMBL5819981; SCHEMBL29379334; BCP22453; LBA11541; 2-N-PROPYL-4-METHYL-6-(1'-METHYLBENZIMIDAZOL-2-YL)BENZIMIDAZOLE; AKOS015839597; AKOS015888106; AB16750; BCP9000111; CS-W019361; DS-0263; FP27230; AC-19086; SY110551; BCP0726000060; DB-021459; D5079; NS00021686; EN300-6764215; 1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazole]; Q27265122; 1,7'-dimethyl-2'-propyl-1h,3'h-[2,5']bibenzoimidazolyl; 2-(1-propyl)-4-methyl-6-(1'-methylbenzimidazol-2-yl)benzimidazole; 2-n-propyl-4-methyl-6-(1-methyl benzimidazole-2-yl)benzimidazole; 1H-Benzimidazole-2-n-propyl-4-methyl-6-(1'-methyl benzimidazole-2'-yl); 1H-Benzimidazole-2-n-propyl-4-methyl-6-(1'methyl benzimidazole-2'-yl); 4-METHYL-6-(1-METHYLBENZIMIDAZOL-2-YL)-2-PROPYLBENZIMIDAZOLE; 4-methyl-6-(1-methyl-1H-benzo[d]imidazol-2-yl)-2-propyl-1H-benzo[d]-imidazole; 4-Methyl-6-(1-methyl-1H-benzo[d]imidazol-2-yl)-2-propyl-1H-benzo[d]imidazole; 1,7'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole;4-Methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole",304.400,C19H20N4,